Technical Analysis for OPK - OPKO Health Inc.

Grade Last Price % Change Price Change
grade B 3.72 -0.27% -0.01
OPK closed down 0.27 percent on Thursday, January 17, 2019, on 79 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical OPK trend table...

Date Alert Name Type % Chg
Jan 17 Doji - Bullish? Reversal 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 17 Overbought Stochastic Strength 0.00%
Jan 16 Wide Bands Range Expansion -0.27%
Jan 16 Overbought Stochastic Strength -0.27%
Jan 15 180 Bullish Setup Bullish Swing Setup -1.59%
Jan 15 NR7 Range Contraction -1.59%
Jan 15 Wide Bands Range Expansion -1.59%
Jan 15 Overbought Stochastic Strength -1.59%
Jan 14 Wide Bands Range Expansion 0.54%

Older signals for OPK ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. The company is developing molecular diagnostics tests to identify molecules or immunobiomarkers for Alzheimer's disease, non-small cell lung cancer, and pancreatic cancer, and other cancers; point-of-care diagnostic tests to detect prostate specific antigen; and laboratory developed tests comprising 4Kscore test for the detection of prostate cancer. It also operates OURLab, a full-service medical laboratory specializing in urologic pathology. In addition, the company is developing CTAP101 Capsules to treat secondary hyperparathyroidism in patients with stage 3 or 4 chronic kidney disease and vitamin D insufficiency; and Fermagate Tablets to treat hyperphosphatemia in end-stage renal disease patients on chronic hemodialysis. Further, it is developing oligonucleotide therapeutics, which are under pre-clinical studies for the treatment of various illnesses, such as cancer, heart disease, metabolic disorders, and genetic anomalies; heparin-derived oligosaccharide for asthma and chronic obstructive pulmonary diseases; influenza vaccines; alpha-galactosyl ceramide analogs for cancer, infectious disease, and autoimmune disease; and rolapitant, a NK-1 candidate that has completed Phase II clinical testing for the prevention of chemotherapy induced nausea and vomiting. Additionally, the company develops and produces specialty active pharmaceutical ingredients; offers ophthalmic and other pharmaceutical products; and provides cardiovascular products, vaccines, antibiotics, gastro-intestinal products, and hormones. It operates in the United States, Chile, Mexico, Israel, and Spain. OPKO Health, Inc. is based in Miami, Florida.
Is OPK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 6.4
52 Week Low 2.34
Average Volume 5,066,491
200-Day Moving Average 4.0972
50-Day Moving Average 3.3768
20-Day Moving Average 3.269
10-Day Moving Average 3.699
Average True Range 0.2419
ADX 32.89
+DI 30.0047
-DI 14.2553
Chandelier Exit (Long, 3 ATRs ) 3.2043
Chandelier Exit (Short, 3 ATRs ) 3.0657
Upper Bollinger Band 4.24
Lower Bollinger Band 2.298
Percent B (%b) 0.73
BandWidth 59.406546
MACD Line 0.1464
MACD Signal Line 0.0818
MACD Histogram 0.0646
Fundamentals Value
Market Cap 2.08 Billion
Num Shares 559 Million
EPS -0.15
Price-to-Earnings (P/E) Ratio -24.80
Price-to-Sales 3.13
Price-to-Book 1.76
PEG Ratio -2.91
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.93
Resistance 3 (R3) 3.92 3.85 3.90
Resistance 2 (R2) 3.85 3.79 3.85 3.88
Resistance 1 (R1) 3.78 3.76 3.82 3.79 3.87
Pivot Point 3.71 3.71 3.72 3.71 3.71
Support 1 (S1) 3.64 3.65 3.68 3.65 3.57
Support 2 (S2) 3.57 3.62 3.57 3.56
Support 3 (S3) 3.50 3.57 3.55
Support 4 (S4) 3.51